Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.

[1]  I. Yakoub-Agha,et al.  Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[2]  H. Agut,et al.  Chromosomally integrated human herpesvirus 6: questions and answers , 2011, Reviews in medical virology.

[3]  D. Weisdorf,et al.  Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary? , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  K. Ishiyama,et al.  Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT , 2011, Bone Marrow Transplantation.

[5]  W. Leisenring,et al.  HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients. , 2011, Blood.

[6]  J. Ritz,et al.  Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis , 2011, Bone Marrow Transplantation.

[7]  K. Baldwin.  Ganciclovir-resistant human herpesvirus-6 encephalitis in a liver transplant patient: a case report , 2011, Journal of NeuroVirology.

[8]  S. Jacobson,et al.  Efficacy of antiviral compounds in human herpesvirus-6-infected glial cells , 2006, Journal of NeuroVirology.

[9]  K. Akashi,et al.  High incidence of human herpes virus 6-associated encephalitis/myelitis following a second unrelated cord blood transplantation. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  T. Yoshikawa.  [Human herpesvirus 6 encephalitis]. , 2010, Brain and nerve = Shinkei kenkyu no shinpo.

[11]  P. Chevallier,et al.  Human herpes virus 6 infection is a hallmark of cord blood transplant in adults and may participate to delayed engraftment: a comparison with matched unrelated donors as stem cell source , 2010, Bone Marrow Transplantation.

[12]  L. White,et al.  Clinical and imaging findings suggesting human herpesvirus 6 encephalitis. , 2010, Pediatric neurology.

[13]  T. Saikawa,et al.  Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients , 2010, Bone Marrow Transplantation.

[14]  M. Harada,et al.  Human herpesvirus-6 encephalitis in hematopoietic SCT recipients in Japan: a retrospective multicenter study , 2009, Bone Marrow Transplantation.

[15]  R. Fukunaga,et al.  Human herpesvirus 6 ganciclovir-resistant strain with amino acid substitutions associated with the death of an allogeneic stem cell transplant recipient. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[16]  L. White,et al.  Extrahippocampal involvement in human herpesvirus 6 encephalitis depicted at MR imaging. , 2008, Radiology.

[17]  M. Chamberlain,et al.  POST-TRANSPLANT ACUTE LIMBIC ENCEPHALITIS: CLINICAL FEATURES AND RELATIONSHIP TO HHV6 , 2008, Neurology.

[18]  T. Saikawa,et al.  Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation , 2008, Bone Marrow Transplantation.

[19]  J. Wagner,et al.  Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. , 2007, Blood.

[20]  I. Bassett,et al.  Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis. , 2007, Blood.

[21]  H. Leong,et al.  Human Herpesvirus 6 DNA Levels in Cerebrospinal Fluid Due to Primary Infection Differ from Those Due to Chromosomal Viral Integration and Have Implications for Diagnosis of Encephalitis , 2007, Journal of Clinical Microbiology.

[22]  P. Griffiths,et al.  The prevalence of chromosomally integrated human herpesvirus 6 genomes in the blood of UK blood donors , 2007, Journal of medical virology.

[23]  B. Yeap,et al.  Double unrelated reduced-intensity umbilical cord blood transplantation in adults. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[24]  R. Yamazaki,et al.  Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[25]  D. Zerr.  Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[26]  Y. Kanda,et al.  Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients , 2006, International journal of hematology.

[27]  L. Dong,et al.  Surveillance of Active Human Herpesvirus 6 Infection in Chinese Patients after Hematopoietic Stem Cell Transplantation with 3 Different Methods , 2006, International journal of hematology.

[28]  P. Griffiths,et al.  Human Herpesvirus 6 Chromosomal Integration in Immunocompetent Patients Results in High Levels of Viral DNA in Blood, Sera, and Hair Follicles , 2006, Journal of Clinical Microbiology.

[29]  H. Agut,et al.  Identification of human herpesvirus 6 variants A and B by primer-specific real-time PCR may help to revisit their respective role in pathology. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[30]  K. Kashima,et al.  Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. , 2006, The Journal of infectious diseases.

[31]  P. Manna,et al.  Quantitative detection and differentiation of human herpesvirus 6 subtypes in bone marrow transplant patients by using a single real-time polymerase chain reaction assay. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[32]  M. Boeckh,et al.  Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  Y. Ishigatsubo,et al.  Human herpesvirus-6 encephalitis after unrelated cord blood transplantation , 2005, Leukemia and Lymphoma.

[34]  A. Wald,et al.  A population-based study of primary human herpesvirus 6 infection. , 2005, The New England journal of medicine.

[35]  E. De Clercq,et al.  Update on Human Herpesvirus 6 Biology, Clinical Features, and Therapy , 2005, Clinical Microbiology Reviews.

[36]  J. Gribben,et al.  Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age. , 2004, Blood.

[37]  J. Wagner,et al.  Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. , 2004, The New England journal of medicine.

[38]  Catherine J. Wu,et al.  Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation. , 2003, Blood.

[39]  G. Papanicolaou,et al.  Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[40]  K. Yamanishi,et al.  High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. , 2002, Blood.

[41]  P. Chan,et al.  Human herpesvirus-6 encephalitis after unrelated umbilical cord blood transplant in children , 2002, Bone Marrow Transplantation.

[42]  K. Horibe,et al.  Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors. , 2002, The Journal of infectious diseases.

[43]  L. Corey,et al.  Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  J. Mary,et al.  Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients , 2001, British journal of haematology.

[45]  C. Manichanh,et al.  Selection of the same mutation in the U69 protein kinase gene of human herpesvirus-6 after prolonged exposure to ganciclovir in vitro and in vivo. , 2001, The Journal of general virology.

[46]  L. Corey,et al.  Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  V. Emery,et al.  High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients , 2000, British journal of haematology.

[48]  F. Wang,et al.  Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance? , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  F. Wang,et al.  Lymphoproliferative responses to human herpesvirus‐6 variant A and variant B in healthy adults , 1999, Journal of medical virology.

[50]  A. Bosi,et al.  Fatal herpesvirus 6 encephalitis after unrelated bone marrow transplant , 1998, Bone Marrow Transplantation.

[51]  D. Faulds,et al.  Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. , 1998, Drugs.

[52]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.

[53]  L. Baxter‐Lowe,et al.  Prevalence of human herpesvirus 6 variant A and B infections in bone marrow transplant recipients as determined by polymerase chain reaction and sequence-specific oligonucleotide probe hybridization , 1993, Journal of clinical microbiology.

[54]  L. Corey,et al.  Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals , 1993, Journal of clinical microbiology.

[55]  H. Agut,et al.  Homogeneous susceptibility of distinct human herpesvirus 6 strains to antivirals in vitro. , 1991, The Journal of infectious diseases.

[56]  G. Sandford,et al.  Susceptibility of human herpesvirus 6 to antivirals in vitro. , 1990, The Journal of infectious diseases.

[57]  S. Matsumoto,et al.  Enhancement of human herpesvirus 6 replication in adult human lymphocytes by monoclonal antibody to CD3. , 1990, Journal of Infectious Diseases.

[58]  K. Yamanishi,et al.  Seroepidemiology of human herpesvirus 6 infection in normal children and adults , 1989, Journal of clinical microbiology.